Remove society motor-neurone-disease
article thumbnail

Amylyx bags first approval for ALS drug Albrioza

pharmaphorum

“ALS is a devastating disease and can move with startling swiftness,” said Tammy Moore, chief executive of the ALS Society of Canada. There is simply no time to wait with this disease.” ” In ALS, which is also known as motor neurone disease, the nerve cells that control muscle function slowly die off.

FDA 52
article thumbnail

The World of Neuroscience

Berkeley Pharma Tech

From brain structure and function to neuroplasticity, neurodegenerative diseases, and neuroethics, we'll take a deep dive into this fascinating field. Neurodegenerative Diseases Neurodegenerative diseases like Parkinson's and Alzheimer's are among the most crippling conditions that can afflict the nervous system.

52
article thumbnail

People with MND in England and Wales fear losing access to life-extending drug

The Guardian - Pharmaceutical Industry

Exclusive: NHS cost threshold has not been raised by National Institute for Health and Care Excellence since 2004 People with motor neurone disease have spoken of their devastation at a likely loss of access to a life-extending drug due to an NHS cost threshold that has not been raised since 2004.

56